CN110746367B - Synthesis method of 1,2, 4-triazole-3-methyl carboxylate - Google Patents
Synthesis method of 1,2, 4-triazole-3-methyl carboxylate Download PDFInfo
- Publication number
- CN110746367B CN110746367B CN201911275116.5A CN201911275116A CN110746367B CN 110746367 B CN110746367 B CN 110746367B CN 201911275116 A CN201911275116 A CN 201911275116A CN 110746367 B CN110746367 B CN 110746367B
- Authority
- CN
- China
- Prior art keywords
- triazole
- benzyl
- methyl
- reaction
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000001308 synthesis method Methods 0.000 title abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims abstract description 66
- 238000006243 chemical reaction Methods 0.000 claims abstract description 31
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims abstract description 21
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000002904 solvent Substances 0.000 claims abstract description 18
- KDKOUILSLKTPNI-UHFFFAOYSA-N 4-benzyl-1,2,4-triazole Chemical compound C1=NN=CN1CC1=CC=CC=C1 KDKOUILSLKTPNI-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000012074 organic phase Substances 0.000 claims abstract description 16
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims abstract description 16
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 claims abstract description 14
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims abstract description 13
- NSPMIYGKQJPBQR-UHFFFAOYSA-N 4H-1,2,4-triazole Chemical compound C=1N=CNN=1 NSPMIYGKQJPBQR-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000007787 solid Substances 0.000 claims abstract description 11
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims abstract description 10
- PVFOMCVHYWHZJE-UHFFFAOYSA-N trichloroacetyl chloride Chemical compound ClC(=O)C(Cl)(Cl)Cl PVFOMCVHYWHZJE-UHFFFAOYSA-N 0.000 claims abstract description 9
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 claims abstract description 8
- 229910000027 potassium carbonate Inorganic materials 0.000 claims abstract description 8
- 238000005984 hydrogenation reaction Methods 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 6
- AGEZXYOZHKGVCM-UHFFFAOYSA-N benzyl bromide Chemical compound BrCC1=CC=CC=C1 AGEZXYOZHKGVCM-UHFFFAOYSA-N 0.000 claims abstract description 5
- KCXMKQUNVWSEMD-UHFFFAOYSA-N benzyl chloride Chemical compound ClCC1=CC=CC=C1 KCXMKQUNVWSEMD-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229940073608 benzyl chloride Drugs 0.000 claims abstract description 5
- 239000003054 catalyst Substances 0.000 claims abstract description 5
- 229910000029 sodium carbonate Inorganic materials 0.000 claims abstract description 4
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims abstract description 3
- 238000001914 filtration Methods 0.000 claims abstract description 3
- 238000010791 quenching Methods 0.000 claims abstract description 3
- 230000000171 quenching effect Effects 0.000 claims abstract description 3
- 238000000034 method Methods 0.000 claims description 8
- QMPFMODFBNEYJH-UHFFFAOYSA-N methyl 1h-1,2,4-triazole-5-carboxylate Chemical compound COC(=O)C1=NC=NN1 QMPFMODFBNEYJH-UHFFFAOYSA-N 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- 230000002194 synthesizing effect Effects 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 4
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 claims description 2
- 239000002994 raw material Substances 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 11
- 239000002351 wastewater Substances 0.000 abstract description 8
- 230000003321 amplification Effects 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract description 2
- 239000003814 drug Substances 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 238000003199 nucleic acid amplification method Methods 0.000 abstract description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 12
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 238000010907 mechanical stirring Methods 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 3
- 239000012295 chemical reaction liquid Substances 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- WRUSYDRVBLXDTL-UHFFFAOYSA-N methyl 4-benzyl-1,2,4-triazole-3-carboxylate Chemical compound COC(=O)C1=NN=CN1CC1=CC=CC=C1 WRUSYDRVBLXDTL-UHFFFAOYSA-N 0.000 description 3
- 229960000329 ribavirin Drugs 0.000 description 3
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 3
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 125000006278 bromobenzyl group Chemical group 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229910052731 fluorine Inorganic materials 0.000 description 2
- 239000011737 fluorine Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 2
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 description 1
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 description 1
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000032050 esterification Effects 0.000 description 1
- 238000005886 esterification reaction Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 206010023332 keratitis Diseases 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000010288 sodium nitrite Nutrition 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
- 230000029812 viral genome replication Effects 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
- C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Abstract
The invention provides a synthesis method of 1,2, 4-triazole-3-methyl carboxylate, and particularly relates to the technical field of medicines, 1,2, 4-triazole, potassium carbonate or sodium carbonate, benzyl bromide or benzyl chloride are heated in a DMF solvent for 8-10 h to react, water is added for quenching reaction, MTBE is extracted to obtain an organic phase, 4-benzyl-1, 2, 4-triazole solid obtained by concentrating the organic phase is dissolved in THF, trichloroacetyl chloride is added and cooled for reaction, triethylamine or N, N-diisopropylethylamine is dropwise added, methanol is slowly added into a reaction system, and the organic phase is obtained by reaction; concentrating an organic phase to obtain 4-benzyl-1, 2, 4-triazole-3-methyl carboxylate, carrying out hydrogenation reaction at 0.5Mpa for 8-10 h under the condition of a catalyst Pd/C, filtering, concentrating a solvent, and recrystallizing methanol to obtain the product 1,2, 4-triazole-3-methyl carboxylate. The invention has the advantages of simple preparation method, less waste water generated in the amplification production and the like.
Description
Technical Field
The invention belongs to the technical field of medicines, and particularly relates to a synthesis method of 1,2, 4-triazole-3-methyl carboxylate.
Background
Methyl 1,2, 4-triazole-3-carboxylate (CAS: 4928-88-5) is an important intermediate of antiviral drug ribavirin (ribavirin). Ribavirin can inhibit ribose synthesis, interfere DNA synthesis and prevent virus replication, is clinically applied to early treatment of viral hepatitis, and can treat simple keratitis, epidemic conjunctivitis and influenza.
Currently, 1,2, 4-triazole-3-methyl carboxylate is industrially prepared by mainly reacting aminoguanidine with oxalic acid in water to obtain 1,2, 4-triazole-5-amino-3-carboxylic acid, and performing denitrification with sodium nitrite and esterification with concentrated sulfuric acid to obtain 1,2, 4-triazole-3-methyl carboxylate. The chemical formula is as follows:
the process can generate a large amount of wastewater which is difficult to treat industrially in each step in industrial production, and under the current environment-friendly situation, the process is eliminated, and a new preparation process of the methyl 1,2, 4-triazole-3-carboxylate needs to be developed.
Disclosure of Invention
Aiming at the defects, the invention aims to provide a synthesis method of 1,2, 4-triazole-3-methyl carboxylate, solves the problems of a large amount of wastewater generated in the reaction of the 1,2, 4-triazole-3-methyl carboxylate and the like, and aims to provide a novel preparation method of the 1,2, 4-triazole-3-methyl carboxylate, and has the advantages of simple preparation method, less wastewater generated in amplification production and the like; the invention is a brand-new preparation method of the 1,2, 4-triazole-3-methyl carboxylate, and provides a new synthesis idea for similar compounds.
The invention provides the following technical scheme:
a method for synthesizing 1,2, 4-triazole-3-methyl carboxylate comprises the following steps:
the specific reaction steps are as follows:
heating and reacting S1, 1,2, 4-triazole, potassium carbonate or sodium carbonate, benzyl bromide or benzyl chloride in a DMF (dimethyl formamide) solvent for 8-10 h, adding water for quenching reaction, extracting MTBE (methyl tert-butyl ether) to obtain an organic phase, and concentrating the organic phase to obtain 4-benzyl-1, 2, 4-triazole solid;
s2, dissolving 4-benzyl-1, 2, 4-triazole in THF, adding trichloroacetyl chloride, cooling to react to 0-5 ℃, dropwise adding triethylamine or N, N-diisopropylethylamine, reacting for 2h at the temperature, slowly adding methanol to the reaction system, reacting for 2h at the temperature of 0-5 ℃, adding water and MTBE, collecting an organic phase,
s3, concentrating an organic phase to obtain 4-benzyl-1, 2, 4-triazole-3-methyl carboxylate, carrying out 0.5Mpa hydrogenation reaction on the 4-benzyl-1, 2, 4-triazole-3-methyl carboxylate under the conditions of a solvent methanol and a catalyst Pd/C for 8-10 h, filtering, concentrating the solvent, and recrystallizing the methanol to obtain the product 1,2, 4-triazole-3-methyl carboxylate.
Preferably, in the step S1, the mass ratio of the solvent to the 1,2, 4-triazole is 8: 1-10: 1; the molar ratio of benzyl bromide or benzyl chloride to 1,2, 4-triazole is 1.1: 1-1.2: 1; the molar ratio of the potassium carbonate or the potassium carbonate to the 1,2, 4-triazole is 2.2: 1-2.5: 1;
preferably, in the step S2, the raw material is trichloroacetyl chloride, and the molar ratio of the trichloroacetyl chloride to the solid 4-benzyl-1, 2, 4-triazole is 1.1:1 to 1.2: 1; the molar ratio of the methanol to the 4-benzyl-1, 2, 4-triazole solid is 2: 1-2.5: 1.
Preferably, in the step S2, the solvent is tetrahydrofuran, and the mass ratio of the tetrahydrofuran to the 4-benzyl-1, 2, 4-triazole solid is 5: 1-6: 1; the molar ratio of triethylamine or N, N-diisopropylethylamine to 4-benzyl-1, 2, 4-triazole solid is 2: 1-2.5: 1.
Preferably, in the step S3, the mass ratio of the methanol to the 4-benzyl-1, 2, 4-triazole-3-carboxylic acid methyl ester is 8: 1-10: 1; the catalyst is 10% Pd/C, and the mass ratio of the 10% Pd/C to methanol to 4-benzyl-1, 2, 4-triazole-3-methyl carboxylate is 0.005: 1-0.01: 1.
The invention has the beneficial effects that:
the invention solves the problems of a large amount of wastewater generated in the reaction of the existing 1,2, 4-triazole-3-methyl carboxylate, and the like, provides a novel preparation method of the 1,2, 4-triazole-3-methyl carboxylate, and has the advantages of simple preparation method, less wastewater generated in large-scale production, and the like; the invention is a brand-new preparation method of the 1,2, 4-triazole-3-methyl carboxylate, and provides a new synthesis idea for similar compounds.
Detailed Description
Example 1
S1, adding 1,2, 4-triazole (0.5Kg, 7.24mol), potassium carbonate (1.0Kg, 16.67mol), DMF3Kg and bromobenzyl (1.4Kg, 8.19mol) into a 10L four-neck flask with a mechanical stirring, a thermometer and a condenser, heating to 80 ℃ for reaction for 10h, cooling to room temperature, pouring the reaction solution into 6Kg of ice water, extracting 3L +2L of MTBE, combining organic phases, decompressing and spin-drying to obtain 0.8Kg of intermediate 4-benzyl-1, 2, 4-triazole, with the yield of 70%. HNMR (solvent CDCl 3; internal standard TMS): δ 5.24(s,2H), δ 7.16-7.18(m,2H), δ 7.24-7.19(m,3H), δ 7.88(s,1H), δ 8.01(s,1H)
S2, adding 4-benzyl-1, 2, 4-triazole (0.8g, 5.03mol), THF4.5Kg, trichloroacetyl chloride (1.05Kg, 5.78mol) into a 5L four-neck flask with mechanical stirring, thermometer and nitrogen protection, cooling the reaction system to 0-5 ℃, slowly dropwise adding triethylamine (1.17Kg, 11.57mol), reacting at 0-5 ℃ for 2h after dropwise adding, dropwise adding methanol (0.5Kg, 15.63mol) at the temperature, reacting at 0-5 ℃ for 2h after dropwise adding, pouring the reaction liquid into 5Kg of ice water, extracting with 3L +2L of MTBE, combining organic phases, and performing rotary drying under reduced pressure to obtain 0.85Kg of intermediate methyl 4-benzyl-1, 2, 4-triazole-3-carboxylate, wherein the yield is 78%. HNMR (solvent CDCl 3; internal standard TMS): δ 4.00(s,3H), δ 5.82(s,2H), δ 7.31-7.36(m,5H), δ 8.02(s, 1H);
s3, adding 4-benzyl-1, 2, 4-triazole-3-methyl carboxylate (0.85Kg, 3.91mol), methanol 8Kg, 10% Pd/C7g into a 15L pressure hydrogenation reaction kettle, replacing the reaction kettle with nitrogen for 3 times, wherein the hydrogenation pressure of a reaction system is 0.5Mpa, the reaction temperature is 35 ℃, the reaction condition is 8 hours, the reaction system has no obvious pressure change, hydrogen in reaction fluorine is removed, the nitrogen is replaced for 3 times, Pd/C is filtered out, the methanol is washed, the obtained filtrate is decompressed, dried in a spinning mode and crystallized by 200mL of methanol to obtain 0.42Kg of 1,2, 4-triazole-3-methyl carboxylate, and the yield is 84%. HNMR (solvent DMSO-d 6; internal standard TMS): δ 3.85(s,3H), δ 8.67(s,1H), δ 13.94(s, 1H); the sample map is consistent with the standard map in comparison;
example 2
S1, adding 1,2, 4-triazole (0.6Kg, 8.69mol), potassium carbonate (1.1Kg, 18.34mol), DMF3Kg and bromobenzyl (1.4Kg, 8.78mol) into a 10L four-neck flask with a mechanical stirring, a thermometer and a condenser, heating to 75 ℃ for reaction for 9 hours, cooling to room temperature, pouring the reaction liquid into 5Kg of ice water, extracting with 3L +2L of MTBE, combining organic phases, and performing rotary drying under reduced pressure to obtain 0.89 Kg of intermediate 4-benzyl-1, 2, 4-triazole with yield of 73%. HNMR (solvent CDCl 3; internal standard TMS): δ 5.24(s,2H), δ 7.16-7.18(m,2H), δ 7.24-7.19(m,3H), δ 7.88(s,1H), δ 8.01(s,1H)
S2, adding 4-benzyl-1, 2, 4-triazole (0.85g, 5.34mol), THF4.55Kg, trichloroacetyl chloride (1.1Kg, 6.06mol) into a 5L four-neck flask with mechanical stirring, thermometer and nitrogen protection, cooling the reaction system to 0-5 ℃, slowly dropwise adding triethylamine (1.2Kg, 11.87mol), reacting at 0-5 ℃ for 2 hours after dropwise adding, dropwise adding methanol (0.55Kg, 17.19mol) at the temperature, reacting at 0-5 ℃ for 2 hours after dropwise adding, pouring the reaction liquid into 5Kg of ice water, extracting with 3L +2L of MTBE, combining organic phases, and performing rotary drying under reduced pressure to obtain an intermediate methyl 4-benzyl-1, 2, 4-triazole-3-carboxylate of 0.88Kg, wherein the yield is 79%. HNMR (solvent CDCl 3; internal standard TMS): δ 4.00(s,3H), δ 5.82(s,2H), δ 7.31-7.36(m,5H), δ 8.02(s, 1H);
s3, adding 4-benzyl-1, 2, 4-triazole-3-methyl carboxylate (0.9Kg, 4.14mol), methanol 8.2Kg, 10% Pd/C7g into a 15L pressure hydrogenation reaction kettle, replacing the reaction kettle with nitrogen for 3 times, wherein the hydrogenation pressure of a reaction system is 0.5Mpa, the reaction temperature is 35 ℃, the reaction condition is 8 hours, the reaction system has no obvious pressure change, hydrogen in reaction fluorine is removed, nitrogen is replaced for 3 times, Pd/C is filtered out, methanol is washed, the obtained filtrate is decompressed, dried and crystallized by 200mL of methanol to obtain 0.46Kg of 1,2, 4-triazole-3-methyl carboxylate, and the yield is 86%. HNMR (solvent DMSO-d 6; internal standard TMS): δ 3.85(s,3H), δ 8.67(s,1H), δ 13.94(s, 1H); the sample map is consistent with the standard map in comparison;
the invention solves the problems of a large amount of wastewater generated in the reaction of the existing 1,2, 4-triazole-3-methyl carboxylate, and the like, provides a novel preparation method of the 1,2, 4-triazole-3-methyl carboxylate, and has the advantages of simple preparation method, less wastewater generated in large-scale production, and the like; the invention is a brand-new preparation method of the 1,2, 4-triazole-3-methyl carboxylate, and provides a new synthesis idea for similar compounds.
Although the present invention has been described in detail with reference to the foregoing embodiments, those skilled in the art will understand that various changes, modifications and substitutions can be made without departing from the spirit and scope of the invention as defined by the appended claims. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.
Claims (5)
1. A method for synthesizing 1,2, 4-triazole-3-methyl carboxylate is characterized in that,
specifically, the reaction equation is as follows:
the specific reaction steps are as follows:
heating and reacting S1, 1,2, 4-triazole, potassium carbonate or sodium carbonate, benzyl bromide or benzyl chloride in a DMF (dimethyl formamide) solvent for 8-10 h, adding water for quenching reaction, extracting MTBE (methyl tert-butyl ether) to obtain an organic phase, and concentrating the organic phase to obtain 4-benzyl-1, 2, 4-triazole solid;
s2, dissolving 4-benzyl-1, 2, 4-triazole in THF, adding trichloroacetyl chloride, cooling to react to 0-5 ℃, dropwise adding triethylamine or N, N-diisopropylethylamine, reacting for 2h at the temperature, slowly adding methanol to the reaction system, reacting for 2h at the temperature of 0-5 ℃, adding water and MTBE, collecting an organic phase,
s3, concentrating an organic phase to obtain 4-benzyl-1, 2, 4-triazole-3-methyl carboxylate, carrying out 0.5Mpa hydrogenation reaction on the 4-benzyl-1, 2, 4-triazole-3-methyl carboxylate under the conditions of a solvent methanol and a catalyst Pd/C for 8-10 h, filtering, concentrating the solvent, and recrystallizing the methanol to obtain the product 1,2, 4-triazole-3-methyl carboxylate.
2. The method for synthesizing methyl 1,2, 4-triazole-3-carboxylate according to claim 1, which is characterized by comprising the following steps: in the step S1, the mass ratio of the solvent to the 1,2, 4-triazole is 8: 1-10: 1; the molar ratio of benzyl bromide or benzyl chloride to 1,2, 4-triazole is 1.1: 1-1.2: 1; the molar ratio of the potassium carbonate or the sodium carbonate to the 1,2, 4-triazole is 2.2: 1-2.5: 1.
3. The method for synthesizing methyl 1,2, 4-triazole-3-carboxylate according to claim 2, characterized in that: in the step S2, the raw material is trichloroacetyl chloride, and the molar ratio of the trichloroacetyl chloride to the 4-benzyl-1, 2, 4-triazole solid is 1.1: 1-1.2: 1; the molar ratio of the methanol to the 4-benzyl-1, 2, 4-triazole solid is 2: 1-2.5: 1.
4. The method for synthesizing methyl 1,2, 4-triazole-3-carboxylate according to claim 3, characterized in that: in the step S2, the solvent is tetrahydrofuran, and the mass ratio of the tetrahydrofuran to the 4-benzyl-1, 2, 4-triazole solid is 5: 1-6: 1; the molar ratio of triethylamine or N, N-diisopropylethylamine to 4-benzyl-1, 2, 4-triazole solid is 2: 1-2.5: 1.
5. The method for synthesizing methyl 1,2, 4-triazole-3-carboxylate according to claim 4, characterized in that: in the step S3, the mass ratio of methanol to 4-benzyl-1, 2, 4-triazole-3-methyl carboxylate is 8: 1-10: 1; the catalyst is 10% Pd/C, and the mass ratio of the 10% Pd/C to methanol to 4-benzyl-1, 2, 4-triazole-3-methyl carboxylate is 0.005: 1-0.01: 1.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911275116.5A CN110746367B (en) | 2019-12-12 | 2019-12-12 | Synthesis method of 1,2, 4-triazole-3-methyl carboxylate |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201911275116.5A CN110746367B (en) | 2019-12-12 | 2019-12-12 | Synthesis method of 1,2, 4-triazole-3-methyl carboxylate |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN110746367A CN110746367A (en) | 2020-02-04 |
| CN110746367B true CN110746367B (en) | 2022-03-29 |
Family
ID=69285919
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201911275116.5A Active CN110746367B (en) | 2019-12-12 | 2019-12-12 | Synthesis method of 1,2, 4-triazole-3-methyl carboxylate |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN110746367B (en) |
-
2019
- 2019-12-12 CN CN201911275116.5A patent/CN110746367B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN110746367A (en) | 2020-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2013026391A1 (en) | Synthesis method of azoxystrobin and exclusive intermediate in the synthesis thereof | |
| CN108409625B (en) | Preparation method of 2-pyrrolidone compound | |
| CN110337434B (en) | Process for preparing 2-cyanoimidazole compounds | |
| CN111808034B (en) | Method for synthesizing 1,2, 4-triazole-3-methyl carboxylate | |
| CN108467396A (en) | A kind of preparation method of Ganciclovir | |
| CN110746367B (en) | Synthesis method of 1,2, 4-triazole-3-methyl carboxylate | |
| CN115417816B (en) | Preparation method of 3, 6-dibromo-1-chloro-isoquinoline | |
| KR20090066910A (en) | Improved method for preparing L-3-O-substituted-ascorbic acid | |
| CN109232222B (en) | A kind of preparation method of (E)-oct-4-ene-1,8-dioic acid | |
| CN112500446B (en) | Synthetic method of 2 '-fluoro-2' -deoxyuridine | |
| CN111004141B (en) | New method for synthesizing nintedanib intermediate 2-chloro-N-methyl-N- (4-nitrophenyl) acetamide | |
| CN115611860B (en) | Method for synthesizing nilaparib | |
| CN115286568B (en) | Preparation method of 2-hydroxy-4-trifluoromethyl pyridine | |
| CN112812066B (en) | A kind of synthetic method of dihydropyrimidinone compound | |
| CN114380835B (en) | Preparation method of 7- (3,4-dimethoxyphenyl) -2-pyrazole [1,5-A ] pyrimidine carboxylic acid | |
| CN103373963B (en) | Intermediate of pazopanib hydrochloride and preparation method thereof | |
| CN111269149B (en) | Production process of 5- (3,3-dimethylguanidino) -2-oxopentanoic acid | |
| CN111018782B (en) | Preparation method of 9-aminoacridine and derivatives thereof | |
| KR101894091B1 (en) | New method for preparation of chromanone derivatives | |
| CN110092751B (en) | Synthesis method of 2-alkyl quinoline | |
| CN116621754A (en) | The preparation method of pyrrolidone-3-β'-amino derivatives | |
| CN111362989A (en) | Preparation method of Sofosbuvir key intermediate | |
| CN111217709A (en) | Preparation method of (1-fluorocyclopropyl) methylamine hydrochloride | |
| CN111574540B (en) | Preparation method of Degatinib | |
| CN116283810B (en) | Preparation method of isoxazole compound |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |